MAM
RCUS icon

Martingale Asset Management’s Arcus Biosciences RCUS Stock Holding History

Martingale Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,426
Closed -$245K – 817
2024
Q4 		$245K Hold
16,426
– – 0.01% 719
2024
Q3 		$251K Buy
+16,426
New +$259K 0.01% 735
2024
Q2 		– Sell
-19,825
Closed -$374K – 836
2024
Q1 		$374K Sell
19,825
-704
-3% -$12.2K 0.01% 669
2023
Q4 		$392K Sell
20,529
-9
-0% -$144 0.01% 657
2023
Q3 		$369K Sell
20,538
-506
-2% -$10.2K 0.01% 653
2023
Q2 		$427K Sell
21,044
-2,209
-9% -$42.1K 0.01% 644
2023
Q1 		$424K Buy
+23,253
New +$444K 0.01% 656
2021
Q4 		– Sell
-15,800
Closed -$551K – 881
2021
Q3 		$551K Buy
15,800
+4,100
+35% +$128K 0.01% 650
2021
Q2 		$322K Buy
+11,700
New +$334K ﹤0.01% 707
2021
Q1 		– Sell
-12,453
Closed -$324K – 902
2020
Q4 		$324K Sell
12,453
-49,540
-80% -$1.2M ﹤0.01% 723
2020
Q3 		$1.06M Sell
61,993
-32,400
-34% -$724K 0.01% 618
2020
Q2 		$2.34M Buy
+94,393
New +$2.55M 0.03% 476

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Martingale Asset Management's RCUS Position: Q1 2025 in Review

Martingale Asset Management sold out of Arcus Biosciences (RCUS) in Q1 2025, closing a stake of 16,426 shares — an estimated $245K sold.

Martingale Asset Management first reported a position in RCUS in Q2 2020 and held it in 12 quarters. The position peaked at $2.34M in Q2 2020. 186 funds tracked by Wall St. Rank hold RCUS as of Q1 2025.

  • Martingale Asset Management reported no remaining Arcus Biosciences position as of Q1 2025 after selling out during the quarter.
  • Martingale Asset Management sold 16,426 Arcus Biosciences shares in Q1 2025, an estimated $245K.
  • Martingale Asset Management first reported a position in Arcus Biosciences in Q2 2020 and held it in 12 quarters.
  • Martingale Asset Management's Arcus Biosciences position peaked at $2.34M in Q2 2020.
  • 186 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2025.

Based on Martingale Asset Management's 13F filing for Q1 2025, filed 14 May 2025.